» Articles » PMID: 31491822

Cortical Neurodevelopment in Pre-manifest Huntington's Disease

Overview
Journal Neuroimage Clin
Publisher Elsevier
Specialties Neurology
Radiology
Date 2019 Sep 8
PMID 31491822
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The expression of the HTT CAG repeat expansion mutation causes neurodegeneration in Huntington's disease (HD).

Objectives: In light of the - mainly in-vitro - evidence suggesting an additional role of huntingtin in neurodevelopment we used 3T MRI to test the hypothesis that in CAG-expanded individuals without clinical signs of HD (preHD) there is evidence for neurodevelopmental abnormalities.

Methods: We specifically investigated the complexity of cortical folding, a measure of cortical neurodevelopment, employing a novel method to quantify local fractal dimension (FD) measures that uses spherical harmonic reconstructions.

Results: The complexity of cortical folding differed at a group level between preHD (n = 57) and healthy volunteers (n = 57) in areas of the motor and visual system as well as temporal cortical areas. However, there was no association between the complexity of cortical folding and the loss in putamen volume that was clearly evident in preHD.

Conclusions: Our results suggest that HTT CAG repeat length may have an influence on cortical folding without evidence that this leads to developmental pathology or was clinically meaningful. This suggests that the HTT CAG-repeat expansion mutation may influence the processes governing cortical neurodevelopment; however, that influence seems independent of the events that lead to neurodegeneration.

Citing Articles

Boundary Complexity of (Sub-) Cortical Areas Predict Deep Brain Stimulation Outcomes in Parkinson's Disease.

Schoen D, Deutsch S, Mehta J, Wang S, Kornak J, Starr P Res Sq. 2024; .

PMID: 39711571 PMC: 11661364. DOI: 10.21203/rs.3.rs-5537857/v1.


Evolution of aberrant brain-wide spatiotemporal dynamics of resting-state networks in a Huntington's disease mouse model.

Vasilkovska T, Verschuuren M, Pustina D, van den Berg M, Van Audekerke J, Pintelon I Clin Transl Med. 2024; 14(10):e70055.

PMID: 39422700 PMC: 11488302. DOI: 10.1002/ctm2.70055.


Fractal Dimension Studies of the Brain Shape in Aging and Neurodegenerative Diseases.

Davidson J, Zhang L, Yue G, Ieva A Adv Neurobiol. 2024; 36:329-363.

PMID: 38468041 DOI: 10.1007/978-3-031-47606-8_17.


Cortical Features in Child and Adolescent Carriers of Mutant Huntingtin (mHTT).

Reasoner E, van der Plas E, Langbehn D, Conrad A, Koscik T, Epping E J Huntingtons Dis. 2022; 11(2):173-178.

PMID: 35275555 PMC: 9177765. DOI: 10.3233/JHD-210512.


Cortical complexity estimation using fractal dimension: A systematic review of the literature on clinical and nonclinical samples.

Meregalli V, Alberti F, Madan C, Meneguzzo P, Miola A, Trevisan N Eur J Neurosci. 2022; 55(6):1547-1583.

PMID: 35229388 PMC: 9313853. DOI: 10.1111/ejn.15631.


References
1.
Cattaneo E, Zuccato C, Tartari M . Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci. 2005; 6(12):919-30. DOI: 10.1038/nrn1806. View

2.
Nasir J, Floresco S, OKusky J, Diewert V, Richman J, Zeisler J . Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995; 81(5):811-23. DOI: 10.1016/0092-8674(95)90542-1. View

3.
Sandu A, Izard E, Specht K, Beneventi H, Lundervold A, Ystad M . Post-adolescent developmental changes in cortical complexity. Behav Brain Funct. 2014; 10:44. PMC: 4289042. DOI: 10.1186/1744-9081-10-44. View

4.
Nopoulos P, Magnotta V, Mikos A, Paulson H, Andreasen N, Paulsen J . Morphology of the cerebral cortex in preclinical Huntington's disease. Am J Psychiatry. 2007; 164(9):1428-34. DOI: 10.1176/appi.ajp.2007.06081266. View

5.
Kalmanti E, Maris T . Fractal dimension as an index of brain cortical changes throughout life. In Vivo. 2007; 21(4):641-6. View